Synthesis and CB1 receptor activities of novel arachidonyl alcohol derivatives

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 12, 2004, Pages 3231-3234

  Parkkari, Teija ^a   Savinainen, Juha R ^a   Rauhala, Anu L ^a   Tolonen, Tiina L ^a   Nevalainen, Tapio ^a   Laitinen, Jarmo T ^a   Gynther, Jukka ^a   Järvinen, Tomi ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

35S GTP S activation; Cannabinoid; CB1 receptor agonist; Synthesis

Indexed keywords

ALCOHOL DERIVATIVE; ARACHIDONIC ACID DERIVATIVE; ARACHIDONYL ALCOHOL DERIVATIVE; CANNABINOID 1 RECEPTOR; CARBAMIC ACID ESTER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN MEMBRANE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG SCREENING; DRUG SYNTHESIS; ENZYME STABILITY; MALE; NONHUMAN; PROTEIN HYDROLYSIS; RAT; RECEPTOR INTRINSIC ACTIVITY;

ALCOHOLS; ANIMALS; ARACHIDONIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1;

EID: 2442471726     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2004.03.093     Document Type: Article

References (18)

1. Savinainen J.R., Järvinen T., Laine K., Laitinen J.T. Br. J. Pharmacol. 134:2001;664
2. Abadji V., Lin S., Taha G., Griffin G., Stevenson L.A., Pertwee R.G., Makriyannis A. J. Med. Chem. 37:1994;1889
3. Lin S., Khanolkar A.D., Fan P., Goutopoulos A., Qin C., Papahadjis D., Makriyannis A. J. Med. Chem. 41:1998;5353
4. Adams I.B., Ryan W., Singer M., Razdan R.K., Compton D.R., Martin B.R. Life Sci. 56:1995;2041
5. Hanuŝ L., Abu-Lafi S., Fride E., Breuer A., Vogel Z., Shalev D.E., Kustanovich I., Mechoulam R. Proc. Natl. Acad. Sci. U.S.A. 98:2001;3662
6. Oka S., Tsuchie A., Tokumura A., Muramatsu M., Suhara Y., Takayama H., Waku K., Sugiura T. J. Neurochem. 85:2003;1374
7. Suhara Y., Nakane S., Arai S., Takayama H., Waku K., Ishima Y., Sugiura T. Bioorg. Med. Chem. Lett. 11:2001;1985
8. Glabe A.R., Sturgeon K.L., Ghizzoni S.B., Musker W.K., Takahashi J.N. J. Org. Chem. 61:1996;7212
9. Gu L., Dunn J., Dvorak C. Drug Dev. Ind. Pharm. 15:1989;209
10. 3): 7.74-7.72 (m, 1H), 7.65-7.58 (m, 8H), 7.45-7.28 (m, 11H), 4.32 (t, J=4.3 Hz, 1H), 3.88 (dd, J=3.1 Hz, 10.7 Hz, 1H), 3.64 (dd, J=3.1 Hz, 10.7 Hz, 1H), 1.14 (s, 9H), 1.06 (s, 9H).
11. 2O: C 72.63%; H 10.12%. Found C 72.49%, H 10.18%.
12. 2O: C 72.63%; H 10.12%. Found C 72.30%, H 10.30%.
13. Shin I., Lee M.-R., Lee J., Jung M., Lee W., Yoon J. J. Org. Chem. 65:2000;7667
14. Oliver J.E., Doss R.P., Williamson T.R., Carney J.R., DeVilbiss E.D. Tetrahedron. 56:2000;7633
15. Lal B., Gangopadhyay A.K., Rajagopalan R., Ghate A.V. Bioorg. Med. Chem. 6:1998;2061
16. Scriba G.K.E. Arch. Pharm. 326:1993;477
17. Andrews D.M., Cherry P.C., Humber D.C., Jones P.S., Keeling S.P., Martin P.F., Shaw C.D., Swanson S. Eur. J. Med. Chem. 34:1999;563
18. Hay M.P., Wilson W.R., Denny W.A. Tetrahedron. 56:2000;645